Germany seeks ways to give its vaccine campaign momentum
Chancellor Angela Merkel and German state governors are going to talk on Monday with representatives of the pharmaceutical industry beefing up the country’s sluggish vaccination campaign
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Chancellor Angela Merkel and German state governors were planning to talk Monday with representatives of the pharmaceutical industry on ways to beef up the country s sluggish vaccination campaign.
Monday's videoconference, which also will involve the European Union's Executive Commission, comes as finger-pointing in the bloc's most populous country mounts over who is to blame for the slow vaccine rollout.
By Friday, 1.85 million people had received a first vaccine dose in Germany — a country of 83 million — and more than 461,000 had a second dose. In comparison, Britain, a country of 67 million, has given nearly 9 million people a first vaccine shot.
A slew of bad news about delays to vaccine deliveries was alleviated only somewhat by news Sunday night that AstraZeneca has agreed to supply 9 million additional doses of its vaccine to the EU during the first quarter — bringing the total to half what the company originally aimed for.
Pfizer which developed the first widely tested and approved coronavirus vaccine together with German firm BioNTech, has said it expects to increase global production this year from 1.3 million doses to 2 billion doses. BioNTech said Monday that up to 75 million of those additional doses will be delivered to the EU in the second quarter.
The German government has pledged to offer everyone vaccine by late September. In addition to frustration with manufacturers, fingers have been pointed at the EU itself, which ordered the vaccines; Germany's federal government, which distributes them to state authorities; and state governments, which are in charge of the actual vaccinations.
Monday's meeting is meant to help improve coordination, among other things, though Merkel's office has cautioned against expecting too much in the way of immediate results. It hasn't specified what industry representatives will join in.
“We could carry on like last week -- council leaders criticize governors and state ministers, state ministers criticize federal ministers and the federal government, the federal government criticizes the European Commission and all criticize the manufacturers,” Health Minister Jens Spahn, himself a frequent target of criticism, told ZDF television on Sunday.
“The virus is the enemy, the opponent, and no one else,” he said. “We all have responsibility and we are responsible above all for doing better.”
Germany is in its second lockdown, which is currently due to expire Feb. 14. Infection figures are falling, but are still well above the government's target. Germany has seen over 57,100 confirmed deaths in the pandemic.
__
Follow all AP stories on the pandemic at https://apnews.com/coronavirus-pandemic; and https://apnews.com/coronavirus-vaccine; and https://apnews.com/UnderstandingtheOutbreak